Sign in
4

Changes in Ownership

Acumen Pharmaceuticals, Inc. Filed Acc 0001576885-24-000012

Chief Legal Officer & Corp Sec acquired 91,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Meisner Derek M Chief Legal Officer & Corp Sec 2024-01-02 Grant or award +91,000 117,800 D
Derivatives
Meisner Derek M Chief Legal Officer & Corp Sec 2024-01-02 Grant or award · Employee Stock Option (right to buy) +137,000 137,000 D
Loading xslF345X05/wk-form4_1704403314.xml…